comparemela.com
Home
Live Updates
Ursuant Lixt Us5393192027 - Breaking News
Pages:
Latest Breaking News On - Ursuant lixt us5393192027 - Page 1 : comparemela.com
Lixte Biotechnology : Termination of Material Agreement - Form 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO. | May 10, 2023
United states
Westpark capital inc
Company current report on form
Lixte biotechnology holdings inc
Nasdaqstock market
Securities exchange
Exchange commission on
Colorado blvd suite
General instruction
Securities act
Exchange act
Purchase common
Material definitive
Lixte biotechnology holdings
Westpark capital
Sales agreement
vimarsana © 2020. All Rights Reserved.